Empowered Funds’s Maravai LifeSciences MRVI Stock Holding History

Empowered Funds’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$313K	Sell	50,167 -39,994	-44%	-$173K	﹤0.01%	1855
2026 Q1	$255K	Sell	90,161 -5,173	-5%	-$17.5K	﹤0.01%	1902
2025 Q4	$310K	Buy	95,334 +2,019	+2%	+$6.8K	0.01%	846
2025 Q3	$268K	Buy	93,315 +3,271	+4%	+$8.35K	﹤0.01%	1631
2025 Q2	$217K	Buy	90,044 +58,016	+181%	+$122K	﹤0.01%	1619
2025 Q1	$70.8K	Buy	32,028 +3,672	+13%	+$14.5K	﹤0.01%	1597
2024 Q4	$155K	Buy	+28,356	New	+$182K	﹤0.01%	1537

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Empowered Funds's MRVI Position: Q2 2026 in Review

Empowered Funds reduced its Maravai LifeSciences (MRVI) stake by 44% in Q2 2026, selling an estimated $173K and leaving 50,167 shares worth $313K. The position accounts for ﹤0.01% of the portfolio, ranked #1855.

Empowered Funds first reported a position in MRVI in Q4 2024 and has held it in 7 quarters since. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Empowered Funds held 50,167 shares of Maravai LifeSciences worth $313K as of Q2 2026.
Empowered Funds sold 39,994 Maravai LifeSciences shares in Q2 2026, an estimated $173K.
Maravai LifeSciences made up ﹤0.01% of Empowered Funds's portfolio in Q2 2026, its #1855 holding.
Empowered Funds first reported a position in Maravai LifeSciences in Q4 2024 and has held it in 7 quarters since.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.